{
  "retracted": false,
  "timestamp": 1422489600000,
  "updates": [
    {
      "timestamp": 1586536083380,
      "identifier": {
        "doi": "10.1182/blood-2014-12-617654"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/blood-2014-04-531871"
  },
  "publisher": "American Society of Hematology",
  "title": "Irving J, Matheson E, Minto L, et al. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-3430."
}
